Lucien Shaul - Ilex Medical Director
| ILX Stock | 6,848 84.00 1.21% |
Director
Lucien Shaul is Director of Ilex Medical since 2008.
| Age | 76 |
| Tenure | 16 years |
| Phone | 972 3 938 5501 |
| Web | https://www.ilexmedical.com |
Ilex Medical Management Efficiency
The company has return on total asset (ROA) of 0.1165 % which means that it generated a profit of $0.1165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1923 %, meaning that it generated $0.1923 on every $100 dollars invested by stockholders. Ilex Medical's management efficiency ratios could be used to measure how well Ilex Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ido Shelem | Palram | 56 | |
| Irit Dov | Palram | 44 | |
| Meirav MetzgerMoshe | Palram | 41 | |
| Shachar av | Palram | 47 | |
| Shlomo Bason | Nextcom | 52 | |
| Ella Tzur | Palram | 51 | |
| Yoram Sadeh | Palram | 54 | |
| Norit Sion | Nextcom | 46 | |
| Shlomo Basson | Nextcom | 53 | |
| Avner Lushi | Palram | 47 | |
| Yitzhak Goldenberg | Palram | 59 | |
| Amir Yavor | Palram | 46 | |
| Israel Chechick | Nextcom | 73 | |
| Itzhak Edry | Palram | 58 | |
| Israel Tchetchik | Nextcom | 78 | |
| Oded Gillat | Palram | 72 | |
| Haim Keresh | Palram | 57 | |
| Ori Flatau | Palram | 51 | |
| Ron Mor | Palram | 52 | |
| Daniel Sztern | Nextcom | 50 | |
| Lea Zvolon | Palram | 52 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 |
Ilex Medical Leadership Team
Elected by the shareholders, the Ilex Medical's board of directors comprises two types of representatives: Ilex Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ilex. The board's role is to monitor Ilex Medical's management team and ensure that shareholders' interests are well served. Ilex Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ilex Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hilla NissimGabbay, Deputy Vice President-Finance | ||
| Ziv Dahari, Vice President - Business Development | ||
| Lily Ayalon, External Director | ||
| Andrea ADV, Legal Sec | ||
| Iris Perelmuter, Vice President of Sales and Marketing | ||
| Lucien Shaul, Director | ||
| Tamar Galili, Chief Officer | ||
| Andrea SittLevy, General Counsel, Secretary | ||
| Moshe Benshaul, Chairman of the Board | ||
| Yacov Mishan, Chief Officer | ||
| Hugo Chaufan, External Director | ||
| Dror Dean, Director of Human Resources | ||
| M Schachter, Head VP | ||
| Ofer Eden, Vice President - Finance | ||
| Hava Shechter, Independent Director | ||
| Claude Benshaul, VP Technologies | ||
| Roberto Goldstrom, External Independent Director | ||
| Saar Oz, VP Sales | ||
| Moshe Shaul, Chairman of the Board | ||
| Claude Shaul, COO | ||
| Lucien Benshaul, Director | ||
| Amir Kleinstern, CEO Flight | ||
| Netanel Aqua, Finance Director |
Ilex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ilex Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Shares Owned By Insiders | 62.44 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ilex Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ilex Medical's short interest history, or implied volatility extrapolated from Ilex Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ilex Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |